Sign In
Buy CFMS
$2.26
+0 (+0%)
At Close: Nov 30, 2023
3 “Strong Buy” Penny Stocks That Could See Outsized Gains
01:39pm, Wednesday, 24'th Jun 2020
COVID-19 and the ensuing economic shutdowns have changed the rules of the investing game. Amid this unprecendented market shakeup, investors must navigate unfamiliar territory, with the old saws not n
Conformis Announces 510(k) Clearance for iTotal® Identity PS
11:38am, Monday, 22'nd Jun 2020
BILLERICA, Mass., June 22, 2020 -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation.
Here is What Hedge Funds Think About ConforMIS, Inc. (CFMS)
12:19am, Tuesday, 16'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
COVID-19 Impact and Recovery Analysis - Knee Replacement Market 2020-2024 | Rise in Orthopedic Diseases to Boost Growth | Technavio
12:00am, Wednesday, 03'rd Jun 2020
The Global Knee Replacement Market will grow by USD 2.26 bn during 2020-2024
Conformis Announces Settlement of Patent Dispute
11:30am, Thursday, 28'th May 2020
BILLERICA, Mass., May 28, 2020 -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license agreement with Zimmer Biomet Holdings, Inc.,.
Conformis, Inc. (CFMS) congratulates Dr. Malte Asseln for winning the prestigious Klee Prize 2020 for his dissertation and computer-and-image-based workflow on the optimization of knee implant design
Edited Transcript of CFMS earnings conference call or presentation 11-May-20 8:30pm GMT
04:26pm, Tuesday, 12'th May 2020
Q1 2020 Conformis Inc Earnings Call
ConforMIS (CFMS) Reports Q1 Loss, Lags Revenue Estimates
11:25pm, Monday, 11'th May 2020
ConforMIS (CFMS) delivered earnings and revenue surprises of -55.56% and -13.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Conformis Reports First Quarter 2020 Financial Results
08:19pm, Monday, 11'th May 2020
BILLERICA, Mass., May 11, 2020 -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,.
Conformis to Host First Quarter 2020 Financial Results Webcast on May 11, 2020
10:15pm, Tuesday, 05'th May 2020
BILLERICA, Mass., May 05, 2020 -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, May 11, 2020, at 4:30 p.m. Eastern.
ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
04:33pm, Wednesday, 29'th Apr 2020
ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Covid-19 Hurting Sales of Medtech Companies
03:15pm, Wednesday, 29'th Apr 2020
With hospitals devoting nearly all their efforts to deal with the pandemic, elective procedures are being put on the backburner Continue reading...
Covid-19 Hurting Sales of Medtech Companies
02:30pm, Wednesday, 29'th Apr 2020
Covid-19 Hurting Sales of Medtech Companies, Stocks: MDT,IH,BSX,CFMS,ZBH,SYK,HOLX,MAXI,IVC,INGN,HRC, release date:Apr 28, 2020
Goldman Sachs Group Inc. Has $104,000 Stake in ConforMIS Inc (NASDAQ:CFMS)
09:50am, Monday, 27'th Apr 2020
Goldman Sachs Group Inc. lifted its stake in shares of ConforMIS Inc (NASDAQ:CFMS) by 261.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commiss
Cambridge biotech to return its PPP loan
11:01pm, Thursday, 23'rd Apr 2020
Wave Life Sciences is testing a synthetic nucleic acid therapy that it believes can correct Duchenne muscular dystrophy patients' inability to product a protein linked to muscle development.
